Suppr超能文献

用锶90进行骨髓消融后脾脏巨核细胞的组织学研究。

Histologic studies of splenic megakaryocytes after bone marrow ablation with strontium 90.

作者信息

Davis E, Corash L, Stenberg P, Levin J

机构信息

Department of Laboratory Medicine, University of California School of Medicine, San Francisco.

出版信息

J Lab Clin Med. 1992 Nov;120(5):767-77.

PMID:1431506
Abstract

We previously showed that purified strontium 90 produced sustained bone marrow ablation in mice, lowering platelet levels to less than 10% of normal 11 days after administration. Platelet levels later rose exclusively from splenic production and were maintained at a stable level (58% of normal) from 20 to 115 days after injection. However, there was no change in the total number or ploidy distribution of splenic megakaryocytes, as immunologically detected by flow cytometry. To further study the characteristics of splenic thrombopoiesis after bone marrow ablation by 90Sr, we measured the frequency, cross-sectional area, and endomitotic figures of histologically recognizable megakaryocytes (as well as bare megakaryocyte nuclei) in mouse spleen sections. During the hematopoietic nadir 9 days after injection of yttrium 90-free 90Sr, the size (area) of megakaryocyte cross-sections (mean +/- SD, 1079.3 +/- 661.6 microns 2; normal, 398.7 +/- 192.8 microns 2) was greater than for any other time studied, but megakaryocyte frequency (corrected for size) did not increase until day 16. Overall, splenic megakaryocytes in marrow-ablated mice 16 or more days after 90Sr injection showed substantial increases (p = 0.001 for both comparisons) in mean area (707.5 +/- 386.2 microns 2) and sectional frequency (mean +/- SEM, 4.52 +/- 0.20 per 1.83 mm2; normal, 0.78 +/- 0.06 per 1.83 mm2). Megakaryocyte bare nuclei and endomitotic figures were also more numerous after 90Sr, injection, suggesting acceleration of megakaryocyte maturation and platelet production. The induction of splenic platelet production after bone marrow ablation is associated with increased size of recognizable megakaryocytes, despite lack of change in overall splenic megakaryocyte ploidy.

摘要

我们之前的研究表明,纯化的锶90可使小鼠骨髓持续消融,给药11天后血小板水平降至正常水平的10%以下。血小板水平随后仅从脾脏产生而上升,并在注射后20至115天维持在稳定水平(正常水平的58%)。然而,通过流式细胞术免疫检测,脾脏巨核细胞的总数或倍性分布没有变化。为了进一步研究90Sr导致骨髓消融后脾脏血小板生成的特征,我们测量了小鼠脾脏切片中组织学上可识别的巨核细胞(以及裸巨核细胞核)的频率、横截面积和核内有丝分裂图像。在注射不含钇90的90Sr后9天的造血最低点期间,巨核细胞横截面的大小(面积)(平均值±标准差,1079.3±661.6平方微米;正常,398.7±192.8平方微米)大于所研究的任何其他时间,但巨核细胞频率(校正大小后)直到第16天才增加。总体而言,90Sr注射后16天或更长时间的骨髓消融小鼠脾脏巨核细胞的平均面积(707.5±386.2平方微米)和截面频率(平均值±标准误,每1.83平方毫米4.52±0.20;正常,每1.83平方毫米0.78±0.06)均显著增加(两次比较p均=0.001)。90Sr注射后,巨核细胞裸核和核内有丝分裂图像也更多,表明巨核细胞成熟和血小板生成加速。骨髓消融后脾脏血小板生成的诱导与可识别的巨核细胞大小增加有关,尽管脾脏巨核细胞总体倍性没有变化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验